Eledon Pharmaceuticals, Inc. (ELDN) Insider Trading

Name: Eledon Pharmaceuticals, Inc. (ELDN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 4, 2026): Gros David-Alexandre C (Chief Executive Officer): Grant/Award of 354,454 shares.

Get alerted when insiders trade ELDN

Email address

Loading company data...

Beta

Loading company details...

Beta